Abeona Therapeutics (ABEO) Research & Development (2011 - 2026)
Abeona Therapeutics (ABEO) posted quarterly Research & Development of $9.6 million for Q1 2026, down 3.88% year-over-year from $9.9 million in Q1 2025, and up 42.36% quarter-over-quarter from $6.7 million in Q4 2025.
Abeona Therapeutics (ABEO) Research & Development (2011 - 2026) Analysis & Trends
Abeona Therapeutics' Research & Development history runs 16 years deep, the most recent figure standing at $9.6 million for Q1 2026.
- In Q1 2026, Research & Development fell 3.88% year-over-year to $9.6 million; the TTM figure through Mar 2026 stood at $26.4 million (down 28.76% YoY), while the FY2025 annual figure was $26.8 million, down 21.97% from the prior year.
- Research & Development for Q1 2026 stood at $9.6 million, up from $6.7 million in the prior quarter.
- The five-year high for Research & Development was $10.5 million in Q1 2022, with the low at $4.2 million in Q3 2025.
- The 5-year median for Research & Development is $7.4 million (2023), against an average of $7.7 million.
- Peak annual rise in Research & Development reached 37.94% in 2025, while the deepest fall reached 52.85% in 2025.
- Abeona Therapeutics' Research & Development stood at $6.3 million in 2022, then increased by 17.65% to $7.4 million in 2023, then climbed by 21.89% to $9.0 million in 2024, then fell by 25.37% to $6.7 million in 2025, then surged by 42.36% to $9.6 million in 2026.
- Business Quant data shows ABEO's Research & Development at $9.6 million in Q1 2026, $6.7 million in Q4 2025, and $4.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 993.80 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.63 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.37 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 394.92 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 612.28 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 1,146.05 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 97.90 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 413.13 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 210.03 Mn |
| 10 | Abeona Therapeutics | 342.78 Mn | 195.96 Mn | 7.20 Mn | 5.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.02 Mn |
| Mar 31, 2026 | 9.56 Mn |
| Dec 31, 2025 | 6.71 Mn |
| Sep 30, 2025 | 4.22 Mn |
| Jun 30, 2025 | 5.94 Mn |
| Mar 31, 2025 | 9.94 Mn |
| Dec 31, 2024 | 8.99 Mn |
| Sep 30, 2024 | 8.94 Mn |
| Jun 30, 2024 | 9.22 Mn |
| Mar 31, 2024 | 7.21 Mn |
| Dec 31, 2023 | 7.38 Mn |
| Sep 30, 2023 | 7.15 Mn |
| Jun 30, 2023 | 8.52 Mn |
| Mar 31, 2023 | 8.04 Mn |
| Dec 31, 2022 | 6.27 Mn |
| Sep 30, 2022 | 5.49 Mn |
| Jun 30, 2022 | 6.66 Mn |
| Mar 31, 2022 | 10.55 Mn |
| Dec 31, 2021 | 12.80 Mn |
| Sep 30, 2021 | 9.06 Mn |